6,678 trials
Type 2 Diabetes Mellitus · Insomnia · Sleep Disorder
Primary: Subjective Total Sleep Time — 6.4; 7.0; 6.7; 6.7 hours — p=0.15
Child Development
Primary: Simpson's Index of Diversity (Alpha Diversity) in Intestinal Microbiome — 10.2; 8.8; 9.7; 9.6 Index score
COVID 19 Associated Coagulopathy
Primary: Mortality — 18; 13 Participants
Atrial Fibrillation and Flutter
Primary: Heart Rate Control — 8; 4 Participants
Diarrhea · COVID-19
Primary: Measure of Daily Stool Frequency for Patients With COVID Treated With Bismuth — 3 bowel movements
Postoperative Pain
Primary: Postoperative Pain Score — 4.2; 4.5 units on a scale
Anesthesia
Primary: Time to Extubation — 230.5; 242.4 Minutes
Sarcoidosis, Pulmonary
Primary: DBT: Number of Participants in Each Category of Assessment Based on Forced Vital Capacity (FVC), a Pulmonary Function Test Parameter at Week 24 — 10; 7; 12; 12…
Psoriasis
Primary: Improvement in Quality of Life Measured by Change From Baseline in Psychological General Well-Being Scale — 78; 3.7; 8.0 score on a scale — p=<0.001
Genotype 1 Hepatitis C Virus
Primary: The Number of Subjects Who Achieve Negative RNA in Alcoholics — 14 Participants
Type 2 Diabetes
Primary: JNK-1 Protein in MNC — 0.943; 0.801; 1.106; 0.789 Arbitrary Units
Attention Deficit Disorder With Hyperactivity
Primary: Attention Deficit Hyperactivity Disorder Rating Scale - 4th Edition (ADHD-RS-IV) Preschool Version Total Score Change From End of Open Label Phase (Baseline) to End of…
COVID-19
Primary: 28-days Mortality Rate — 1; 34; 43; 52 Participants — p=<0.001
Insomnia · Posttraumatic Stress Disorder
Primary: Change in Insomnia Severity Index Score From Baseline. — 6.8; 8.6 units on a scale — p=<.05
Cervical Radiculitis · Pain
Primary: Change in Strength in Both Groups After CESI. — 25; 30; 35; 30 Participants — p=.05